Results 201 to 210 of about 1,742,061 (410)

Molecular characterization of acute myeloid leukemia patients who relapse more than 3 years after diagnosis: an exome sequencing study of 31 patients

open access: yesHaematologica, 2020
Luise Hartmann   +6 more
doaj   +1 more source

Blood histamine in myelogenous leukemia [PDF]

open access: bronze, 1951
Michael B. Shimkin   +4 more
openalex   +1 more source

Plasma metabolic landscape unveils key regulators of leukemia subtype progression. [PDF]

open access: yesFuture Sci OA
Liang C   +7 more
europepmc   +1 more source

USP10 Inhibits Ferroptosis via Deubiquinating POLR2A in Head and Neck Squamous Cell Carcinoma

open access: yesAdvanced Science, EarlyView.
This study identifies USP10 as a novel deubiquitinase that antagonizes ferroptosis in head and neck squamous cell carcinoma (HNSCC). Mechanistically, USP10 directly stabilizes POLR2A protein through post‐translational deubiquitination, enabling POLR2A‐mediated transcriptional activation of SLC7A11, a key ferroptosis inhibitor.
Diekuo Zhang   +13 more
wiley   +1 more source

URETHANE THERAPY IN LEUKEMIA [PDF]

open access: bronze, 1948
Adolph J. Creskoff   +2 more
openalex   +1 more source

RIG‐I‐Inducing Small Molecules Potently Inhibit HMA‐Resistant AML Through Igniting the Overloaded dsRNA Arsenal

open access: yesAdvanced Science, EarlyView.
This study reveals a novel mechanism of resistance to DNA hypomethylating agents (HMAs) in acute myeloid leukemia (AML), and identifies all‐trans retinoic acid (ATRA) and tamibarotene (TAM) as potent agents that overcome HMA resistance by reactivating the interferon anticancer immune response. The findings offer promising therapeutic strategies for HMA‐
Xueqin Chen   +18 more
wiley   +1 more source

Chronic Myeloid Leukemia

open access: yesMethods in Molecular Biology, 2017
Rüdiger Hehlmann
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy